Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies

Leukemia. 2019 Sep;33(9):2315-2319. doi: 10.1038/s41375-019-0455-3. Epub 2019 Apr 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't